Filing Details

Accession Number:
0001209191-11-041971
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-02 16:02:32
Reporting Period:
2011-08-01
Filing Date:
2011-08-02
Accepted Time:
2011-08-02 16:02:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
31791 Perkinelmer Inc PKI Laboratory Analytical Instruments (3826) 042052042
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1224110 F Robert Friel 940 Winter Street
Waltham MA 02451
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-08-01 20,000 $24.45 520,922 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Friel on May 10, 2011. Under the plan, Mr. Friel has now sold 40,000 shares and will sell up to an aggregate of 40,000 more shares prior to May 11, 2012 and up to an additional 80,000 shares issuable under options to purchase the Issuer's common stock prior to the January 3, 2012 expiration date of such options.
  2. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $24.270 to $24.670. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  3. The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Issuer's Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account.